Overcoming Proteasome Inhibitor Resistance - HealthTree for Multiple Myeloma
[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Overcoming Proteasome Inhibitor Resistance, Muhamed Baljevic, MD, University of Nebraska

Overcoming Proteasome Inhibitor Resistance, Muhamed Baljevic, MD, University of Nebraska image

Overcoming Proteasome Inhibitor Resistance, Muhamed Baljevic, MD, University of Nebraska

Podcast
event May 28, 2018 / 11:00AM MDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Muhamed Baljevic, MD

University of Nebraska

Interview Date: May 28, 2018

Many patients' myeloma can become resistant to an important class of drugs use for myeloma care - proteasome inhibitors. Most patients (70%) will respond to these drugs as single therapies but some patients can be resistant initially. Researchers at MD Anderson Cancer Center and the University of Nebraska found that expression of a gene called MUC20 could help predict how sensitive or resistant patients would be to proteasome inhibitors. They also found that the MUC20 protein could be potentially impacted by an already FDA-approved drug offered by Amgen called cabozantinib. 

Dr. Baljevic shares a clinical trial using cabozantinib with carfilzomib for patients who have become refractory (resistant) to carfilzomib. The study is open at the University of Nebraska and MD Anderson Cancer Center. Cabozantinib has shown the ability to reverse the resistance to proteasome inhibitors. 

Thanks to our episode sponsor, Celgene Corporation

Schedule & Agenda

Event panelist Dr. Muhamed Baljevic & Jenny Ahlstrom
11:00 AM
Discussion
Dr. Muhamed Baljevic & Jenny Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.